Found 7 matching trials
Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer
PHASE1This study is being done to select an appropriate TF2 bsMAb dose suitable f...
Location
Georgetown University Medical Center
Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies
PHASE1This phase I/II trial studies the side effects and best dose of anti-cluste...
Location
Fred Hutch/University of Washington Cancer Consortium
TF2- Small Cell Lung Cancer Radio Immunotherapy
PHASE1Lung cancer is currently the leading cause of cancer death in both men and ...
Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer
PHASE1This study will investigate the toxicity, safety and pharmacokinetics of pr...
Location
Radboud University Nijmegen Medical Centre
Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
PHASE1This phase I trial studies pretargeted radioimmunotherapy and donor periphe...
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
PHASE1This phase I/II trial studies the side effects and best dose of 211\^astati...
Location
Fred Hutch/University of Washington Cancer Consortium
Pretargeted Radioimmunotherapy in Metastatic Colorectal Cancer
PHASE1Phase I/II, Open-labeled, Prospective, Multi-center study of a Pretargeted ...